Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RMTI
stocks logo

RMTI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
16.55M
-32.91%
-0.040
+100%
17.75M
-6.16%
-0.035
-12.5%
17.87M
+11.19%
-0.030
-40%
Estimates Revision
The market is revising Downward the revenue expectations for Rockwell Medical, Inc. (RMTI) for FY2025, with the revenue forecasts being adjusted by -1.51% over the past three months. During the same period, the stock price has changed by -37.04%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.51%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-2.78%
In Past 3 Month
Stock Price
Go Down
down Image
-37.04%
In Past 3 Month
Wall Street analysts forecast RMTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RMTI is 3.75 USD with a low forecast of 2.50 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast RMTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RMTI is 3.75 USD with a low forecast of 2.50 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.020
sliders
Low
2.50
Averages
3.75
High
5.00
Current: 1.020
sliders
Low
2.50
Averages
3.75
High
5.00
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$3
2025-11-13
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$3
2025-11-13
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Rockwell Medical to $2.50 from $3 and keeps a Buy rating on the shares after the company reported a "slight" top-line miss in Q3. The firm, which has adjusted its long-term forecasts, tells investors that the company's revenue base, while "meaningfully more diversified" than in the past, may not benefit from large contracts as much as in the past.
HC Wainwright & Co.
Raghuram Selvaraju
Strong Buy
Maintains
$7 → $3
2025-03-24
Reason
HC Wainwright & Co.
Raghuram Selvaraju
Price Target
$7 → $3
2025-03-24
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Raghuram Selvaraju
Strong Buy
Reiterates
$7
2024-12-23
Reason
HC Wainwright & Co.
Raghuram Selvaraju
Price Target
$7
2024-12-23
Reiterates
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Rockwell Medical Inc (RMTI.O) is -8.16, compared to its 5-year average forward P/E of -0.10. For a more detailed relative valuation and DCF analysis to assess Rockwell Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.10
Current PE
-8.16
Overvalued PE
62.97
Undervalued PE
-63.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-14.90
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
63.56
Undervalued EV/EBITDA
-93.35

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.64
Current PS
0.00
Overvalued PS
1.05
Undervalued PS
0.23
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

RMTI News & Events

Events Timeline

(ET)
2025-11-12
06:08:39
Rockwell Medical reaffirms revenue forecast of $65M-$70M for FY25
select
2025-11-12
06:07:25
Rockwell Medical announces Q3 adjusted EPS of 0 cents compared to 9 cents in the previous year.
select
2025-07-08 (ET)
2025-07-08
06:03:13
Rockwell Medical and Innovative Renal Care sign three-year partnership agreement
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
11-18Newsfilter
Rockwell Medical Names Joe Dawson to Its Board of Directors

  • Board Appointment: Rockwell Medical has appointed Joe Dawson to its board of directors, bringing over 25 years of experience in the renal care and cardiovascular markets, while Andrea Heslin Smiley has resigned to pursue other opportunities.

  • Expertise and Contributions: Dawson's background includes significant operational experience, contract negotiations, and leadership roles in FDA-regulated markets, which will aid Rockwell Medical in expanding its market share and optimizing manufacturing.

  • Company Overview: Rockwell Medical specializes in developing and distributing hemodialysis products for dialysis providers, focusing on innovative growth strategies and high-quality customer service to support patients with end-stage kidney disease.

  • Recognition and Commitment: The company has been recognized as a Great Place to Work for 2023-2025 and aims to deliver life-sustaining dialysis solutions while maintaining a commitment to reliability and customer service.

[object Object]
Preview
9.5
11-12SeekingAlpha
Rockwell Medical Reports Non-GAAP EPS of $0.00 and Revenue of $15.93M, Falling Short by $0.31M; Maintains Full-Year Guidance

  • Q3 Financial Performance: Rockwell Medical reported a non-GAAP EPS of $0.00 and revenue of $15.93 million, a 43.8% decrease year-over-year, missing expectations by $0.31 million.

  • Adjusted EBITDA and Cash Position: The company recorded an adjusted EBITDA of $50,000 for Q3 2025, a decline from $2.8 million in Q3 2024, but an improvement from a loss of $0.2 million in Q2 2025. Their cash position increased to $23.7 million as of September 30, 2025.

  • 2025 Guidance Reiteration: Rockwell Medical reaffirmed its 2025 guidance, projecting net sales between $65 million and $70 million, with a gross margin of 16% to 18% and adjusted EBITDA ranging from a loss of $0.5 million to a profit of $0.5 million.

  • Management Changes and Ratings: Heather Hunter has been promoted to COO, and Seeking Alpha has provided a quant rating on Rockwell Medical, alongside historical earnings data.

[object Object]
Preview
3.0
11-11SeekingAlpha
Rockwell Medical's Q3 Earnings Forecast

  • Earnings Announcement: Rockwell Medical (RMTI) will announce its Q3 earnings results on November 12th, with an expected EPS of -$0.04 and revenue of $16.24M, reflecting significant year-over-year declines.

  • Performance History: Over the past two years, RMTI has beaten EPS estimates 50% of the time and revenue estimates 75% of the time.

  • Management Changes: Heather Hunter has been promoted to COO of Rockwell Medical.

  • Sales Target: The company has reiterated its sales target of $65M-$70M for 2025, supported by new contracts that aim to expand its long-term revenue base.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Rockwell Medical Inc (RMTI) stock price today?

The current price of RMTI is 1.02 USD — it has increased 2.1 % in the last trading day.

arrow icon

What is Rockwell Medical Inc (RMTI)'s business?

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

arrow icon

What is the price predicton of RMTI Stock?

Wall Street analysts forecast RMTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RMTI is 3.75 USD with a low forecast of 2.50 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Rockwell Medical Inc (RMTI)'s revenue for the last quarter?

Rockwell Medical Inc revenue for the last quarter amounts to 15.93M USD, decreased -43.75 % YoY.

arrow icon

What is Rockwell Medical Inc (RMTI)'s earnings per share (EPS) for the last quarter?

Rockwell Medical Inc. EPS for the last quarter amounts to -0.05 USD, decreased -225.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Rockwell Medical Inc (RMTI)'s fundamentals?

The market is revising Downward the revenue expectations for Rockwell Medical, Inc. (RMTI) for FY2025, with the revenue forecasts being adjusted by -1.51% over the past three months. During the same period, the stock price has changed by -37.04%.
arrow icon

How many employees does Rockwell Medical Inc (RMTI). have?

Rockwell Medical Inc (RMTI) has 244 emplpoyees as of December 05 2025.

arrow icon

What is Rockwell Medical Inc (RMTI) market cap?

Today RMTI has the market capitalization of 40.19M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free